News
At 5 years, iFR found as effective and safe as FFR for guiding PCI intervention
Five-year data reinforce prior finding: iFR and FFR are comparably effective and safe for guiding revascularization.
News
Practicing telepsychiatry: Include backup plans, ground rules
Ideally, telepsychiatry will function much like an inpatient office visit, but the dynamics differ – as do the things that can go wrong.
News
Short DAPT course beneficial after PCI in ‘bi-risk’ patients
MASTER DAPT subgroup analysis supports short antiplatelet course in cases of high bleeding and ischemic risk.
News
SUGAR trial finds superior stent for those with diabetes and CAD
In noninferiority trial, the Cre8 EVO stent was associated with fewer target lesion failures than the Resolute Onyx at 1 year in the setting of...
News
Renal denervation remains only promising, per latest meta-analysis
A fairly large body of evidence showing safety and efficacy for renal denervation is not enough for an indication.
News
FDA not recognizing efficacy of psychopharmacologic therapies
If this reorientation is going to lead to the broad indications the newer drugs likely deserve, “we have to move the FDA along,” said Dr. Stephen...
News
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
News
Cannabis use: Messages remain mixed across diagnoses
Medscape Live and this news organization are owned by the same parent company. Dr. Martinez and Dr. Sarris reported no financial conflicts of...
News
Major increase seen in cosmeceutical alternatives to topical hydroquinone
Cosmeceutical alternatives for hydroquinone, an agent now restricted by the FDA, have proliferated.
News
In atopic dermatitis trial, abrocitinib offers faster itch relief than dupilumab
The primary endpoint for pruritus at 2 weeks was reached by nearly twice as many patients randomly assigned to abrocitinib.
News
Lessons from an ethnic skin center: Awareness and respect for diversity
Working through the complications from unfamiliar cosmetic choices depends on acceptance and an open mind.
News
JAK inhibitor provides impressive hair growth for patients with alopecia areata
There was a clear dose effect; hair growth increased more quickly with the 4-mg dose of baricitinib than with the 2-mg dose.
News
Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trial
These findings not only include substantial clinical efficacy but good tolerability with “no serious treatment-related adverse events.”
News
Rapid response needed for rare filler injection complications
“Swift and aggressive treatment is required to avoid irreversible changes.”
News
Nonsteroidal topical found effective for psoriasis in 52-week study
“This is likely to be very useful in patients who are looking for a topical therapy for skin folds or the face, where there is a need for well-...